FDA advisors endorse weight-loss drug Qnexa
U.S. reviewers said proponents of a new drug for obesity of Vivus Inc. on Wednesday that outweigh the benefits for the health of the risks of birth defects of the heart and the drug.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment